Characterization of a conjunctival melanoma cell line CM-AS16, newly-established from a metastatic Han Chinese patient-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of a conjunctival melanoma cell line CM-AS16, newly-established from a metastatic Han Chinese patient

Published:2018-08 Issue: Volume:173 Page:51-63
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Li Yongyun,Shang Qingfeng,Li Peng,Cao Jinfeng,Zhu Liqi,Jager Martine J.^ORCID,Fan Xianqun,Ge Shengfang,Jia Renbing

Funder

National Health and Family Planning Commission of China

Science and Technology Commission of Shanghai

National Natural Science Foundation of China

SMC-ChenXing Yong Scholar Program

Shanghai Municipal Education Commission-Gaofeng Clinical Medicine

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference50 articles.

1. Establishment and characterization of human ocular melanoma cell lines;Aubert;Int. J. Canc.,1993

2. A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor;Bendell;Br. J. Canc.,2017

3. Molecular pathology of melanocytic tumors;Busam;Semin. Diagn. Pathol.,2013

4. Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy;Cao;Oncotarget,2017

5. The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The american college of surgeons commission on cancer and the american cancer society;Chang;Cancer,1998

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing of propafenone to discover novel anti-tumor agents by impairing homologous recombination to delay DNA damage recovery of rare disease conjunctival melanoma;European Journal of Medicinal Chemistry;2023-03

2. Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78–FOXM1–KIF20A pathway;Acta Pharmaceutica Sinica B;2022-10

3. Preclinical models in ophthalmic oncology—a narrative review;Annals of Eye Science;2022-06

4. New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells;International Journal of Molecular Sciences;2022-01-27

5. LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction;Cancer Letters;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3